Page last updated: 2024-10-25

diazepam and Diabetes, Gestational

diazepam has been researched along with Diabetes, Gestational in 1 studies

Diazepam: A benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant, and amnesic properties and a long duration of action. Its actions are mediated by enhancement of GAMMA-AMINOBUTYRIC ACID activity.
diazepam : A 1,4-benzodiazepinone that is 1,3-dihydro-2H-1,4-benzodiazepin-2-one substituted by a chloro group at position 7, a methyl group at position 1 and a phenyl group at position 5.

Diabetes, Gestational: Diabetes mellitus induced by PREGNANCY but resolved at the end of pregnancy. It does not include previously diagnosed diabetics who become pregnant (PREGNANCY IN DIABETICS). Gestational diabetes usually develops in late pregnancy when insulin antagonistic hormones peaks leading to INSULIN RESISTANCE; GLUCOSE INTOLERANCE; and HYPERGLYCEMIA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Schürfeld, R1
Baratashvili, E1
Würfel, M1
Blüher, M1
Stumvoll, M1
Tönjes, A1
Ebert, T1

Other Studies

1 other study available for diazepam and Diabetes, Gestational

ArticleYear
Circulating acyl-CoA-binding protein/diazepam-binding inhibitor in gestational diabetes mellitus.
    Reproductive biology and endocrinology : RB&E, 2023, Oct-23, Volume: 21, Issue:1

    Topics: Diabetes, Gestational; Diazepam; Diazepam Binding Inhibitor; Female; Humans; Multivariate Analysis;

2023